Quantcast State of the Union: May 3rd Follow-Up | NFCA
Skip Navigation Links

State of the Union: May 3rd Follow-Up

On Thursday, May 3, 2012 the National Foundation for Celiac Awareness (NFCA) hosted a live video stream/special event, "State of the Union: A Live Chat with Experts on Gluten-Related Disorders." As thought-leaders in the field and recognized internationally for their work and research, these experts devoted countless hours to create this presentation and throughout the year, work tirelessly to create a better understanding of celiac disease and other gluten-related disorders and an increased awareness to help improve the quality of life for consumers living gluten-free. This free event was brought to you as an educational service as part of National Celiac Awareness Month. Listen to a replay below.*

Download a transcript of this recording

*As most members of the celiac disease community know, Italian physicians and scientists have been at the forefront of treatment and research for many years. Therefore, it seems highly fitting that the event’s two physician-experts are native-born Italians. Dr. Alessio Fasano is from Salerno, Italy, and Dr. Stefano Guandalini is from Rome. Dr. Guandalini is Founder and Medical Director of the University of Chicago Celiac Disease Center, and Dr. Fasano founded the Center for Celiac Research at the University of Maryland School of Medicine in 1996.

For a follow-up blog post featuring these panelists: Q&A with Leading Celiac Experts on Gluten Sensitivity, Schizophrenia and Nutritional Deficiencies

Additional Details

During the webcast “State of the Union: Live Chat with Experts on Gluten-Related Disorders,” one audience participant commented on a particular topic discussed by panelist Melinda Dennis, MS, RD, LDN. To ensure that accurate information is communicated, NFCA is sharing the following answer from Melinda.

Comment: “She's recommending D2 not D3.  D2 is prescription and works okay, but D3 is the natural form.”

Response from Melinda Dennis: Yes, D2 is the more common prescription form (therapeutic [high] dosing) to which I referred in the webinar. D3 is the form we like to recommend as a general over-the-counter vitamin D supplement (such as a gluten-free calcium and vitamin D supplement). D3 is the more active, natural form.  More details on supplements and other dietary recommendations for celiac disease and non-celiac gluten sensitivity can be found in our book, Real Life with Celiac Disease, which was written by 50 international celiac experts in gastroenterology and nutrition.

NFCA has received many inquiries wondering if we will be providing a transcription of this event. A transcript is now available: Download the transcript. Also, NFCA is aware of the technological difficulties experienced particularly during Dr. Guandalini’s presentation. Fortunately, Dr. Guandalini's presentation was well recorded and his entire talk is very easy to hear when listening to the recorded webcast.

Don’t forget to save the date for the 15th International Celiac Disease Symposium in Chicago September 22-25, 2013. You can learn more by visiting www.ICDS2013.org

To learn more about Dr. Fasano’s work and the topics he discussed, we encourage you to visit his website where you can read the latest information on the research conducted by the University of Maryland Center for Celiac Research.

Highlights include:
Consensus article on gluten-related disorders
Other research articles
(Non-celiac) Gluten sensitivity FAQs
Infants At-Risk of Celiac Disease May Benefit From Delayed Exposure to Gluten
Differences between celiac disease and (non-celiac) gluten sensitivity

 
  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter